This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Cepheid Inc. for the provision of GeneXpert IV-2 CLIA diagnostic systems, printers, and associated equipment and services. The $79,625 contract award does not have a set-aside designation, as Cepheid was selected as the sole-source provider.
The contract supports the Naval Health Research Center's (NHRC) requirement for molecular diagnostic equipment and consumables to be used in its laboratories. Cepheid is a leading provider of molecular diagnostic solutions, and its GeneXpert systems have been utilized by various federal agencies, including the Department of Veterans Affairs, to support COVID-19 and other infectious disease testing programs. As a subsidiary of the Danaher Corporation, Cepheid has a history of supplying specialized equipment and services to the U.S. government through both contract awards and grants.